Добірка наукової літератури з теми "Complications oculaires"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся зі списками актуальних статей, книг, дисертацій, тез та інших наукових джерел на тему "Complications oculaires".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Статті в журналах з теми "Complications oculaires":
Regnier, Alain, Mathilde Goetz, and Jean-Yves Douet. "Complications de la chirurgie oculaire chez le cheval." Le Nouveau Praticien Vétérinaire équine 16 (October 2022): 22–36. http://dx.doi.org/10.1051/npvequi/2023006.
Goldstein, Andrei, Julia Hilly, and Julie Laboure-Wolf. "Complications oculaires en anesthésie." Le Praticien en Anesthésie Réanimation 10, no. 6 (December 2006): 439–44. http://dx.doi.org/10.1016/s1279-7960(06)75643-1.
Barry, A., AI Baldé, AB Kamissoko, M. Ndong Obiang, M. Sanda, K. Condé, and M. Touré. "Manifestations oculaires au cours des spondyloarthrites en Guinée." Rhumatologie Africaine Francophone 3, no. 2 (October 16, 2022): 6–12. http://dx.doi.org/10.62455/raf.v3i2.34.
Zamalhèto, Z., L. Legheda, H. Dossou-yovo, M. Gounongbé, and I. Sounouvou. "L’œil des patients souffrant de connectivites à Cotonou (Bénin)." Rhumatologie Africaine Francophone 1, no. 2 (August 31, 2021): 17–22. http://dx.doi.org/10.62455/raf.v1i2.6.
Martenet, A. C. "Complications oculaires du SIDA - Problèmes diagnostiques." Klinische Monatsblätter für Augenheilkunde 200, no. 05 (May 1992): 555–58. http://dx.doi.org/10.1055/s-2008-1045826.
Nghe, Marie-Claire. "Complications oculaires en chirurgie non ophtalmologique." Le Praticien en Anesthésie Réanimation 22, no. 4 (September 2018): 195–202. http://dx.doi.org/10.1016/j.pratan.2018.06.008.
Héron, E., I. Rossignol, A. Chibani, F. Mihoubi-Mantout, M. Baudrimont, M. Sterkers, and S. Feldman-Billard. "Complications oculaires de la maladie de Horton." La Revue de Médecine Interne 28 (June 2007): 57. http://dx.doi.org/10.1016/j.revmed.2007.03.077.
MAZARI, Fettouma. "The place of eye exam in the follow-up of the arterial hypertension." Batna Journal of Medical Sciences (BJMS) 6, no. 1 (July 1, 2019): 77–81. http://dx.doi.org/10.48087/bjmscr.2019.6124.
Mathis, T., V. Fortoul, L. Kodjikian, and P. Denis. "Complications oculaires de l’implant esthétique coloré NewColorIris®." Journal Français d'Ophtalmologie 38, no. 6 (June 2015): e107-e109. http://dx.doi.org/10.1016/j.jfo.2014.12.004.
Ez-zahraoui, M. R., M. Y. El Bakkouri, I. Hajji, and A. Moutaouakil. "Complications oculaires secondaires au traitement d’un ptérygion par apipuncture." Journal Français d'Ophtalmologie 40, no. 5 (May 2017): 447–49. http://dx.doi.org/10.1016/j.jfo.2016.11.020.
Дисертації з теми "Complications oculaires":
Mercié, Martial. "Syndromes paranéoplasiques oculaires." Bordeaux 2, 1997. http://www.theses.fr/1997BOR23016.
BAKRI, MOTASSEM. "Les complications oculaires des angiomes immatures de la paupiere : a propos de 11 observations." Lyon 1, 1989. http://www.theses.fr/1989LYO1M293.
Pokitonoff, Mathilde Catherine Sophie. "Contribution à l'étude des complications oculaires de l'influenza Thèse pour le doctorat en médecine présentée et soutenue le jeudi 24 juillet 1890 /." Paris : BIUM, 2003. http://www.bium.univ-paris5.fr/histmed/medica/cote?TPAR1890x362.
Cassagne, Myriam. "Etude physiopathologique des complications oculaires observées chez des patients atteints de dermatite atopique traitée par Dupilumab." Electronic Thesis or Diss., Toulouse 3, 2023. http://www.theses.fr/2023TOU30288.
Dupilumab has proven its efficacy in the treatment of moderate to severe atopic dermatitis (AD). However, the occurrence of ocular adverse events (OAEs) has been reported. The objectives of this work were to describe the incidence and nature of OAEs induced by dupilumab in AD patients, to evaluate potential predisposing factors, and to understand their molecular bases. We conducted a first single-center, prospective, real-life study in adult AD patients treated with dupilumab, who were systematically examined by an ophthalmologist before and during treatment. We included 46 patients with a median initial SCORing of AD (SCORAD) of 46.0 (interquartile range: 34.5-55.5). 34.8% of patients experienced OAEs, often mild to moderate, but leading to interruption of dupilumab for two patients. The majority of patients developed or worsened dry eye. Six patients (13%) developed conjunctivitis de novo. Dupilumab-induced OAEs were associated with dry eye with superficial punctuate keratitis (Odds ratio (OR) = 6.3 95% confidence interval (CI): [1.3-31.6]), eyelid eczema (OR= 8.7; 95% CI: [1.8-40.6]), a history of food allergy (OR = 3.8; 95% CI: [1.002-14.070]) and/or serum IgE levels > 1.000 kU/L (OR = 10.6; 95% CI: [1.2-91.3]). We then participated to a national multicenter study which included 181 patients. Thirty-four patients (18.7%) presented blepharoconjunctivitis induced by dupilumab: either de novo (n=32; 17.6%) or by worsening of a pre-existing condition (n=2; 1.1%). Most events (27/34; 79.4%) were moderate. Multivariate analysis showed that AD with head and neck involvement (OR = 7.254; 95% CI [1.938-30.07]; p = 0.004), erythroderma (OR = 5.635; 95% CI [1.635] -21.50]; p = 0.007) and the presence of dry eye syndrome before treatment (OR = 3.51; 95% CI [3.158-13.90]; p = 0.031) were independent factors associated with dupilumab-induced blepharoconjunctivitis. The SCORAD or the response to treatment (% improvement in SCORAD at W16), a history of allergic conjunctivitis, asthma or rhinitis were also not significantly associated with the occurrence of OAE. Finally, we conducted a bicentric study, comparing the transcriptome (analyzed by DNA microarrays and RT-qPCR) and the expression of the chemokine CCL20 (by ELISA) of conjunctival cells, collected by conjunctival impression, on AD patients before (M0) and 4 months after dupilumab beginning (M4). Thirty-six patients were included and divided in two groups, according their ophthalmological status at M4: one group of 12 who developed OAE (OAE+) and another group of 24 who did not (OAE-). In multiple analysis of the full transcriptome, we found 52 differentially expressed genes (DEG) between OAE+/M0 and OAE-/M0, 113 DEG between OAE+/M4 and OAE-/M4, two DEG between OAE+/M0 and OAE+/M4, and none DEG between OAE-/M0 and OAE-/M4. Ingenuity Pathway Analysis enrichment with a special interest in diseases, mainly indicated a psoriasis signature. Among the 15 DEG selected for RT-qPCR validation, only 7 were significant: CCL20, IL-19, NOX1, NOS2, SLC26A4 and S100A12 were up-regulated, whereas MUC-7 was downregulated in OAE+/M4 vs OAE-/M4 patients. CCL20 protein quantification by ELISA confirmed an over-expression between M0 and M4 for the two groups. In conclusion, most cases of dupilumab-induced blepharoconjunctivitis are de novo. Pre-existing factors (dry eye syndrome, AD with eyelid, head and neck) are associated with an increased risk of OAE. Dupilumab seems to switch AD immunological profile of OAE patients from Th2 to Th17, particularly involved in psoriasis
Lellouche, Eric. "L'immunité locale dans deux parasitoses oculaires, toxoplasmose et onchocércose." Paris 5, 1993. http://www.theses.fr/1993PA05P084.
Gaboriaud, Corinne. "Manifestations ophtalmologiques des vascularites : à propos de deux cas." Bordeaux 2, 1992. http://www.theses.fr/1992BOR2M076.
JAIME, SONIA. "Complications immediates et secondaires des plaies penetrantes du segment anterieur (limbe inclus, corps etrangers intra-oculaires inclus, sequelles eloignees exclues)." Lyon 1, 1988. http://www.theses.fr/1988LYO1M213.
Belso, Laurence. "Syndrome de Terson : étude rétrospective à propos de quatre cas." Montpellier 1, 1997. http://www.theses.fr/1997MON11163.
Godenèche, Benoît. "Glaucome évolutif à pression intra-oculaire normalisée. Etude à partir de l'enregistrement sur le nycthémère de la tension oculaire couplé à la tension artérielle." Bordeaux 2, 1997. http://www.theses.fr/1997BOR23078.
PLOEGAERTS, PHILIPPE. "Segment posterieur et radiations ionisantes : a propos de 36 cas de tumeur intra-oculaire traites par radiotherapie." Lille 2, 1991. http://www.theses.fr/1991LIL2M016.
Книги з теми "Complications oculaires":
1934-, Fraunfelder Frederick T., Roy Frederick Hampton, and Meyer S. Martha, eds. Current ocular therapy 3. Philadelphia: Saunders, 1990.
Ophthalmology, American Academy of. Lens and cataract, 2007-2008. 2nd ed. [San Francisco]: American Academy of Ophthalmology, 2007.
Takao, Kumazawa, Kruger Lawrence, and Mizumura Kazue, eds. The polymodal receptor: A gateway to pathological pain. Amsterdam: Elsevier, 1996.
Frauenfelder and Roy. Current Ocular Therapy, Book 3. W.B. Saunders Company, 1989.
(Editor), T. Kumazawa, L. Kruger (Editor), and K. Mizumura (Editor), eds. The Polymodal Receptor - A Gateway to Pathological Pain (Progress in Brain Research). Elsevier Science, 1996.
Тези доповідей конференцій з теми "Complications oculaires":
Landric, C., C. Alande, and M. Ndiaye. "Apport de la greffe gingivale épithélio conjonctive dans la reconstruction palpébrale." In 66ème Congrès de la SFCO. Les Ulis, France: EDP Sciences, 2020. http://dx.doi.org/10.1051/sfco/20206602014.